Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105718

Metabolic clearance rates and interconversions of estrone and 17β-estradiol in normal males and females

Christopher Longcope, Donald S. Layne, and James F. Tait

Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts

Find articles by Longcope, C. in: PubMed | Google Scholar

Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts

Find articles by Layne, D. in: PubMed | Google Scholar

Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts

Find articles by Tait, J. in: PubMed | Google Scholar

Published January 1, 1968 - More info

Published in Volume 47, Issue 1 on January 1, 1968
J Clin Invest. 1968;47(1):93–106. https://doi.org/10.1172/JCI105718.
© 1968 The American Society for Clinical Investigation
Published January 1, 1968 - Version history
View PDF
Abstract

The continuous infusion of 3H-6,7-estrone and 3H-6,7-estradiol has been used to study the metabolic clearance rate (MCR), the interconversions, and the red cell uptake of these steroids in normal males and females. The whole blood MCR of estrone is 1,990 ± 120 liters per day/m2 (SE) in males and 1,910 ± 100 liters per day/m2 in females. The whole blood MCR of estradiol is 1,600 ± 80 liters per day/m2 in males and 1,360 ± 40 liters per day/m2 in females. The values in females do not vary significantly when studied in the follicular or luteal phase of the cycle. At least 35% of the total estrone metabolism in both sexes is extrasplanchnic and at least 25% of the total estradiol metabolism in males, and 15% in females is extrasplanchnic. The [ρ]BB2,1 [transfer constant of estradiol to estrone, which is equivalent to the fraction of the precursor (estradiol) converted to the product (estrone) when both the infusion of the precursor and the measurement of the product are in peripheral blood] is 15%; and the [ρ]BB1,2 [transfer constant of estrone to estradiol, which is equivalent to the fraction of the precursor (estrone) converted to product (estradiol) when both the infusion of the precusor and the measurement of the product are in peripheral blood] is 5% in both males and females. Our findings concerning the radioactivity in whole blood, as measured by our procedure, were the following: 15-20% of estrone in both sexes and 15% of estradiol in males is associated with red cells. Only 2% of the whole blood radioactivity of estradiol in females is associated with red cells. Changes in the distribution of radioactivity between plasma and red cells will influence the MCR as calculated from plasma, but not as calculated from whole blood.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 93
page 93
icon of scanned page 94
page 94
icon of scanned page 95
page 95
icon of scanned page 96
page 96
icon of scanned page 97
page 97
icon of scanned page 98
page 98
icon of scanned page 99
page 99
icon of scanned page 100
page 100
icon of scanned page 101
page 101
icon of scanned page 102
page 102
icon of scanned page 103
page 103
icon of scanned page 104
page 104
icon of scanned page 105
page 105
icon of scanned page 106
page 106
Version history
  • Version 1 (January 1, 1968): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts